These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. High CO Bharat A; Angulo M; Sun H; Akbarpour M; Alberro A; Cheng Y; Shigemura M; Berdnikovs S; Welch LC; Kanter JA; Budinger GRS; Lecuona E; Sznajder JI Am J Respir Cell Mol Biol; 2020 Aug; 63(2):244-254. PubMed ID: 32275835 [TBL] [Abstract][Full Text] [Related]
30. Breast tumor metastasis following filgrastim administration due to the SDF-1/CXCR4 pathway. Khalighfard S; Khori V; Esmati E; Ahmadi F; Amiriani T; Poorkhani A; Sadani S; Khodayari S; Khodayari H; Kalhori MR; Keshavarz P; Alizadeh AM Med Oncol; 2023 Jan; 40(2):74. PubMed ID: 36609711 [TBL] [Abstract][Full Text] [Related]
31. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer. Zhu WB; Zhao ZF; Zhou X J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000 [TBL] [Abstract][Full Text] [Related]
32. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms. Tu CC; Arnolds KL; O'Connor CM; Spencer JV J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840 [TBL] [Abstract][Full Text] [Related]
33. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes. Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746 [TBL] [Abstract][Full Text] [Related]
34. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling. Lin Y; Ma Q; Li L; Wang H Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404 [TBL] [Abstract][Full Text] [Related]
35. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice. Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617 [TBL] [Abstract][Full Text] [Related]
36. Noninvasive application of mesenchymal stem cell spheres derived from hESC accelerates wound healing in a CXCL12-CXCR4 axis-dependent manner. Wang X; Jiang B; Sun H; Zheng D; Zhang Z; Yan L; Li E; Wu Y; Xu RH Theranostics; 2019; 9(21):6112-6128. PubMed ID: 31534540 [TBL] [Abstract][Full Text] [Related]
37. Stromal cell-derived factor 1 (SDF-1) accelerated skin wound healing by promoting the migration and proliferation of epidermal stem cells. Guo R; Chai L; Chen L; Chen W; Ge L; Li X; Li H; Li S; Cao C In Vitro Cell Dev Biol Anim; 2015 Jun; 51(6):578-85. PubMed ID: 25636237 [TBL] [Abstract][Full Text] [Related]
38. CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice. Wilson GC; Freeman CM; Kuethe JW; Quillin RC; Nojima H; Schuster R; Blanchard J; Edwards MJ; Caldwell CC; Lentsch AB Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(8):G702-9. PubMed ID: 25721302 [TBL] [Abstract][Full Text] [Related]
39. Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway. Zhang Q; He L; Dong Y; Fei Y; Wen J; Li X; Guan J; Liu F; Zhou T; Li Z; Fan Y; Wang N FASEB J; 2020 Jun; 34(6):7500-7519. PubMed ID: 32281218 [TBL] [Abstract][Full Text] [Related]
40. A New Anti-CXCR4 Antibody That Blocks the CXCR4/SDF-1 Axis and Mobilizes Effector Cells. Broussas M; Boute N; Akla B; Berger S; Beau-Larvor C; Champion T; Robert A; Beck A; Haeuw JF; Goetsch L; Bailly C; Dumontet C; Matthes T; Corvaia N; Klinguer-Hamour C Mol Cancer Ther; 2016 Aug; 15(8):1890-9. PubMed ID: 27297868 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]